These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36706864)

  • 21. Potential antiviral effects of pantethine against SARS-CoV-2.
    Abou-Hamdan M; Saleh R; Mani S; Dournaud P; Metifiot M; Blondot ML; Andreola ML; Abdel-Sater F; De Reggi M; Gressens P; Laforge M
    Sci Rep; 2023 Feb; 13(1):2237. PubMed ID: 36754974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antiviral properties of synthetic histidine derivatives containing membranotropic volumetrical carbocycles in their molecule against SARS-CoV-2 virus
    Garaev TM; Grebennikova TV; Avdeeva VV; Lebedeva VV; Larichev VF
    Vopr Virusol; 2023 Mar; 68(1):18-25. PubMed ID: 36961232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters.
    Yuan S; Wang R; Chan JF; Zhang AJ; Cheng T; Chik KK; Ye ZW; Wang S; Lee AC; Jin L; Li H; Jin DY; Yuen KY; Sun H
    Nat Microbiol; 2020 Nov; 5(11):1439-1448. PubMed ID: 33028965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication.
    Touret F; Gilles M; Barral K; Nougairède A; van Helden J; Decroly E; de Lamballerie X; Coutard B
    Sci Rep; 2020 Aug; 10(1):13093. PubMed ID: 32753646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice.
    Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Tian M; Jin N; Li X
    Virol J; 2021 Feb; 18(1):46. PubMed ID: 33639976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro.
    Murray J; Hogan RJ; Martin DE; Blahunka K; Sancilio FD; Balyan R; Lovern M; Still R; Tripp RA
    Sci Rep; 2021 Sep; 11(1):18085. PubMed ID: 34508172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection.
    Maestro S; Córdoba KM; Olague C; Argemi J; Ávila MA; González-Aseguinolaza G; Smerdou C; Fontanellas A
    Biomed Pharmacother; 2021 May; 137():111384. PubMed ID: 33761605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro.
    Varghese FS; van Woudenbergh E; Overheul GJ; Eleveld MJ; Kurver L; van Heerbeek N; van Laarhoven A; Miesen P; den Hartog G; de Jonge MI; van Rij RP
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in vitro antiviral activity of iodine complexes against SARS-CoV-2.
    Altaf I; Nadeem MF; Hussain N; Nawaz M; Raza S; Shabbir MAB; Ashraf MA; Ali MA; Hassan S; Aziz MW; Matti N; Ashraf M; Ulla I; Fazal S; Rafique S; Mehmood A; Sardar N; Khan MT; Atique HMM; Ashraf S; Tahir Z; Mukhtar N; Yaqub T
    Arch Microbiol; 2021 Sep; 203(7):4743-4749. PubMed ID: 34136927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
    Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
    Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.
    Choy KT; Wong AY; Kaewpreedee P; Sia SF; Chen D; Hui KPY; Chu DKW; Chan MCW; Cheung PP; Huang X; Peiris M; Yen HL
    Antiviral Res; 2020 Jun; 178():104786. PubMed ID: 32251767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amantadine Inhibits SARS-CoV-2 In Vitro.
    Fink K; Nitsche A; Neumann M; Grossegesse M; Eisele KH; Danysz W
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33804989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
    Caly L; Druce JD; Catton MG; Jans DA; Wagstaff KM
    Antiviral Res; 2020 Jun; 178():104787. PubMed ID: 32251768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro.
    Okamoto M; Toyama M; Baba M
    Antiviral Res; 2020 Oct; 182():104902. PubMed ID: 32739404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms.
    Marín-Palma D; Tabares-Guevara JH; Zapata-Cardona MI; Flórez-Álvarez L; Yepes LM; Rugeles MT; Zapata-Builes W; Hernandez JC; Taborda NA
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of the anti-SARS-CoV-2 activity of cationic amphiphilic steroidal compounds.
    Borin A; Coimbra LD; Bispo-Dos-Santos K; Naciuk FF; Fontoura M; Simeoni CL; Gomes GV; Amorim MR; Gravina HD; Shimizu JF; Passos ASC; de Oliveira IM; de Carvalho AC; Cardoso AC; Parise PL; Toledo-Teixeira DA; Sotorilli GE; Persinoti GF; Claro IM; Sabino EC; Alborghetti MR; Rocco SA; Franchini KG; de Souza WM; Oliveira PSL; Cunha TM; Granja F; Proença-Módena JL; Trivella DBB; Bruder M; Cordeiro AT; Marques RE
    Virulence; 2022 Dec; 13(1):1031-1048. PubMed ID: 35734825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aprotinin Inhibits SARS-CoV-2 Replication.
    Bojkova D; Bechtel M; McLaughlin KM; McGreig JE; Klann K; Bellinghausen C; Rohde G; Jonigk D; Braubach P; Ciesek S; Münch C; Wass MN; Michaelis M; Cinatl J
    Cells; 2020 Oct; 9(11):. PubMed ID: 33143316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate.
    Gendrot M; Duflot I; Boxberger M; Delandre O; Jardot P; Le Bideau M; Andreani J; Fonta I; Mosnier J; Rolland C; Hutter S; La Scola B; Pradines B
    Int J Infect Dis; 2020 Oct; 99():437-440. PubMed ID: 32805422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.
    Stegmann KM; Dickmanns A; Gerber S; Nikolova V; Klemke L; Manzini V; Schlösser D; Bierwirth C; Freund J; Sitte M; Lugert R; Salinas G; Meister TL; Pfaender S; Görlich D; Wollnik B; Groß U; Dobbelstein M
    Virus Res; 2021 Sep; 302():198469. PubMed ID: 34090962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.